Work

Significant in-Vitro Activity of a Novel JAK2 Inhibitor in Multiple Myeloma Associated with Preferential Cytotoxicity for CD45+ Myeloma Cells.

Year: 2009

Type: article

Source: Blood

DOI: 10.1182/blood.v114.22.2848.2848

Authors: Vijay Ramakrishnan, Jessica Haug, Teresa Kimlinger, Timothy Halling, Linda Wellik, Animesh D. Pardanani, Ayalew Tefferi, S. Vincent Rajkumar, Shaji Kumar

Institution: Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979490967

FWCI:

Cites:

Cited by:

Related to: 10